Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OTOP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
USH1G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HID1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FDXR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDR2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIN2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL58 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP5H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM104 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCTD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAT9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC9A3R1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD300LF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on